Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation. 2011

Omer Dushek, and Milos Aleksic, and Richard J Wheeler, and Hao Zhang, and Shaun-Paul Cordoba, and Yan-Chun Peng, and Ji-Li Chen, and Vincenzo Cerundolo, and Tao Dong, and Daniel Coombs, and P Anton van der Merwe
Sir William Dunn School of Pathology, University of Oxford, OX1 3RE, UK.

T cell activation, a critical event in adaptive immune responses, depends on productive interactions between T cell receptors (TCRs) and antigens presented as peptide-bound major histocompatibility complexes (pMHCs). Activated T cells lyse infected cells, secrete cytokines, and perform other effector functions with various efficiencies, which depend on the binding parameters of the TCR-pMHC complex. The mechanism through which binding parameters are translated to the efficiency of T cell activation, however, remains controversial. The "affinity model" suggests that the dissociation constant (KD) of the TCR-pMHC complex determines the response, whereas the "productive hit rate model" suggests that the off-rate (koff) is critical. Here, we used mathematical modeling to show that antigen potency, as determined by the EC50 (half-maximal effective concentration), which is used to support KD-based models, could not discriminate between the affinity and the productive hit rate models. Both models predicted a correlation between EC50 and KD, but only the productive hit rate model predicted a correlation between maximal efficacy (Emax), the maximal T cell response induced by pMHC, and koff. We confirmed the predictions made by the productive hit rate model in experiments with cytotoxic T cell clones and a panel of pMHC variants. Thus, we propose that the activity of an antigen is determined by both its potency (EC50) and maximal efficacy (Emax).

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D013816 Thermodynamics A rigorously mathematical analysis of energy relationships (heat, work, temperature, and equilibrium). It describes systems whose states are determined by thermal parameters, such as temperature, in addition to mechanical and electromagnetic parameters. (From Hawley's Condensed Chemical Dictionary, 12th ed) Thermodynamic
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D056704 Adaptive Immunity Protection from an infectious disease agent that is mediated by B- and T- LYMPHOCYTES following exposure to specific antigen, and characterized by IMMUNOLOGIC MEMORY. It can result from either previous infection with that agent or vaccination (IMMUNITY, ACTIVE), or transfer of antibody or lymphocytes from an immune donor (IMMUNIZATION, PASSIVE). Acquired Immunity,Hybrid Immunity,Adaptive Immune Response,Adoptive Immunity,Immunity, Adaptive,Hybrid Immunities,Immune Response, Adaptive,Immunity, Acquired,Immunity, Adoptive,Immunity, Hybrid,Response, Adaptive Immune

Related Publications

Omer Dushek, and Milos Aleksic, and Richard J Wheeler, and Hao Zhang, and Shaun-Paul Cordoba, and Yan-Chun Peng, and Ji-Li Chen, and Vincenzo Cerundolo, and Tao Dong, and Daniel Coombs, and P Anton van der Merwe
January 1988, Annals of the New York Academy of Sciences,
Omer Dushek, and Milos Aleksic, and Richard J Wheeler, and Hao Zhang, and Shaun-Paul Cordoba, and Yan-Chun Peng, and Ji-Li Chen, and Vincenzo Cerundolo, and Tao Dong, and Daniel Coombs, and P Anton van der Merwe
January 2024, Methods in molecular biology (Clifton, N.J.),
Omer Dushek, and Milos Aleksic, and Richard J Wheeler, and Hao Zhang, and Shaun-Paul Cordoba, and Yan-Chun Peng, and Ji-Li Chen, and Vincenzo Cerundolo, and Tao Dong, and Daniel Coombs, and P Anton van der Merwe
May 2024, Journal of translational medicine,
Omer Dushek, and Milos Aleksic, and Richard J Wheeler, and Hao Zhang, and Shaun-Paul Cordoba, and Yan-Chun Peng, and Ji-Li Chen, and Vincenzo Cerundolo, and Tao Dong, and Daniel Coombs, and P Anton van der Merwe
February 1987, European journal of immunology,
Omer Dushek, and Milos Aleksic, and Richard J Wheeler, and Hao Zhang, and Shaun-Paul Cordoba, and Yan-Chun Peng, and Ji-Li Chen, and Vincenzo Cerundolo, and Tao Dong, and Daniel Coombs, and P Anton van der Merwe
February 2001, Immunity,
Omer Dushek, and Milos Aleksic, and Richard J Wheeler, and Hao Zhang, and Shaun-Paul Cordoba, and Yan-Chun Peng, and Ji-Li Chen, and Vincenzo Cerundolo, and Tao Dong, and Daniel Coombs, and P Anton van der Merwe
January 2012, Journal of immunotherapy (Hagerstown, Md. : 1997),
Omer Dushek, and Milos Aleksic, and Richard J Wheeler, and Hao Zhang, and Shaun-Paul Cordoba, and Yan-Chun Peng, and Ji-Li Chen, and Vincenzo Cerundolo, and Tao Dong, and Daniel Coombs, and P Anton van der Merwe
March 1987, Journal of immunology (Baltimore, Md. : 1950),
Omer Dushek, and Milos Aleksic, and Richard J Wheeler, and Hao Zhang, and Shaun-Paul Cordoba, and Yan-Chun Peng, and Ji-Li Chen, and Vincenzo Cerundolo, and Tao Dong, and Daniel Coombs, and P Anton van der Merwe
December 1986, Agents and actions,
Omer Dushek, and Milos Aleksic, and Richard J Wheeler, and Hao Zhang, and Shaun-Paul Cordoba, and Yan-Chun Peng, and Ji-Li Chen, and Vincenzo Cerundolo, and Tao Dong, and Daniel Coombs, and P Anton van der Merwe
January 2020, Frontiers in cell and developmental biology,
Omer Dushek, and Milos Aleksic, and Richard J Wheeler, and Hao Zhang, and Shaun-Paul Cordoba, and Yan-Chun Peng, and Ji-Li Chen, and Vincenzo Cerundolo, and Tao Dong, and Daniel Coombs, and P Anton van der Merwe
April 2010, Molecular immunology,
Copied contents to your clipboard!